This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sakakibara, Y. Articles by Sakakibara, Y. Search for Related Content PubMed PubMed Citation Articles by Sakakibara, Y. Articles by Sakakibara, Y. Social Bookmarking                         What's this?

Upper Extremity Vein Thrombosis: Etiologic Categories, Precipitating Causes, and Management

Osamu Shigeta, MD

Shigemi Ishikawa, MD

Yuji Hiramatsu, MD

Tomoaki Jikuya, MD

Masataka Onizuka, MD

Toshio Mitsui, MD

Yuzuru Sakakibara, MD, FACA

Department of Surgery Institute of Clinical Medicine University of Tsukuba Tsukuba City, Ibaraki, 305-8575 Japan

Although an increasing incidence of upper extremity venous thrombosis (U/E-DVT) has been reported, a relative paucity of information regarding the etiologic categories, precipitating causes, and proper management for this disorder is available. To settle on a strategy for the management of U/E-DVT, retrospective analyses were performed using records from the authors' hospital. In 12 patients (seven men, five women), 61 (mean) years of age, diagnosed as having symptomatic venography-proved U/E-DVT and followed up for 41 (mean) months, etiologic factors, precipitating causes, treatments, and outcomes were retrospectively analyzed. As etiologic factors, five of the patients had neoplastic disease, one had hemodialysis, and two had transvenous pacemaker implan tations. Among various precipitating causes of U/E-DVT, hypoproteinemia was most frequently noted (67%). Various types of therapeutic management were selected: from thrombolysis with urokinase in six, balloon angioplasty in two, thrombectomy in two, and venous bypass surgery in one patient. Pulmonary embolism did not occur in any of the patients and only three of them complained of mild intermittent arm swelling during the follow-up period. Four patients died of neoplastic disease or heart failure (three within the first 6 months).

This study, though limited, suggests that the rate of mortality depends on multiple underlying medical problems in U/E-DVT patients. Low incidences of late postthrom botic sequelae and pulmonary embolism were noted in this series. Symptomatic U/E- DVT patients could be managed conservatively with a revised supplementary therapy for their precipitating causes of U/E-DVT.

Angiology, Vol. 50, No. 7, 547-553 (1999)
DOI: 10.1177/000331979905000704


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?